RIGL logo

Rigel Pharmaceuticals (RIGL)

Profile

Full Name

Rigel Pharmaceuticals, Inc.

Ticker Symbol

RIGL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 29, 2000

Indexes

Not included

Website

http://www.rigel.com

Employees

162

Key Details

Price

$16.68(+2.58%)

Market cap

$297.95M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$179.28M(+53.38% YoY)

Annual EPS

$0.99(+168.75% YoY)

PE ratio

17.74

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$16.68
RIGL price is $16.68

30-Day Relative Volume

0.60
RIGL 30-day relative volume is 0.60

Price Performance

Price Today change

+2.58%
RIGL price is up +2.58% today

Price YTD change

-0.83%
RIGL price is down -0.83% since January 1st

Price 1-year change

+35.61%
RIGL price is up +35.61% year-on-year

Price 3-year change

-42.88%
RIGL price is down -42.88% over the past 3 years

Price Range

Price All-time high

$1068.75
RIGL price is currently -98.44% below its historical high of $1068.75

Price 3-year low

$0.64
RIGL price is currently +2506.25% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$297.95M
RIGL market capitalization is $297.95 million

Market cap 3-year change

-40.69%
RIGL market capitalization is down -40.69% over the past 3 years

Market cap All-time high

$939.37M
RIGL market capitalization is currently -68.28% below its historical high of $939.37 million

Market cap sector rank

63.11%
RIGL market capitalization is higher than 63.11% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.84%
RIGL shares outstanding is up +1.84% year-on-year

Shares Outstanding 3-Year Change

+3.83%
RIGL shares outstanding is up +3.83% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.26
RIGL beta is 1.26

200-day SMA

$16.88
RIGL price is currently -1.21% below its 200-day simple moving average

50-day SMA

$20.08
RIGL price is currently -16.94% below its 50-day simple moving average

RSI

38.40
RIGL 14-day relative strength index is 38.40

Volume

0.60
RIGL 30-day relative volume is 0.60

ATR

$1.35
RIGL average true range is $1.35

10-day Historical Volatility

66.51%
RIGL 10-day historical volatility is 66.51%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$179.28M
RIGL annual revenue is $179.28 million

Revenue Analysts estimate

$197.79M
RIGL annual revenue is currently -9.36% lower than the consensus analysts' forecast

Revenue 1-year change

+53.38%
RIGL annual revenue is up +53.38% year-on-year

Revenue Sector rank

62.15%
RIGL annual revenue is higher than 62.15% of companies in Healthcare sector

EPS

EPS

$0.99
RIGL annual earnings per share is $0.99

EPS Analysts estimate

$1.24
RIGL annual earnings per share is currently -20.37% lower than the consensus analysts' forecast

EPS 1-year change

+168.75%
RIGL annual earnings per share is up +168.75% year-on-year

EPS Sector rank

89.1%
RIGL annual earnings per share is higher than 89.1% of companies in Healthcare sector

Profit

Gross profit

$160.63M
RIGL annual gross profit is $160.63 million

Gross margin

89.60%
RIGL annual gross profit margin is 89.60%

Operating profit

$24.19M
RIGL annual operating income is $24.19 million

Operating margin

13.49%
RIGL annual operating profit margin is 13.49%

Net income

$17.48M
RIGL annual net profit is $17.48 million

Net margin

9.75%
RIGL annual net profit margin is 9.75%

Expenses

Total expenses

$155.09M
RIGL annual total expenses is $155.09 million

Operating expenses

$136.44M
RIGL annual total operating expenses is $136.44 million

Cost of goods sold

$18.65M
RIGL annual cost of goods sold is $18.65 million

Selling, general & administrative expenses

$113.06M
RIGL annual SGA is $113.06 million

Depreciation and amortization

$2.23M
RIGL annual depreciation & amortization is $2.23 million

Interest expense

$7.92M
RIGL annual interest expense is $7.92 million

Income tax

$881.00K
RIGL annual income tax is $881.00 thousand

EBIT & EBITDA

EBIT

$26.28M
RIGL annual earnings before interest & taxes is $26.28 million

EBITDA

$28.51M
RIGL annual EBITDA is $28.51 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$163.98M
RIGL annual total assets is $163.98 million

Non current assets

$28.87M
RIGL annual long term assets is $28.87 million

Current assets

$135.10M
RIGL annual total current assets is $135.10 million

Cash and cash equivalents

$56.75M
RIGL annual cash & cash equivalents is $56.75 million

Accounts receivable

$41.62M
RIGL annual accounts receivable is $41.62 million

Inventory

$6.00M
RIGL annual inventory is $6.00 million

Liabilities

Total liabilities

$160.69M
RIGL annual total liabilities is $160.69 million

Long term liabilities

$97.39M
RIGL annual total long term liabilities is $97.39 million

Current liabilities

$63.30M
RIGL annual total current liabilities is $63.30 million

Accounts payable

$3.34M
RIGL annual accounts payable is $3.34 million

Debt

Total debt

$59.97M
RIGL annual total debt is $59.97 million

Total debt 1-year change

-1.01%
RIGL annual total debt is down -1.01% year-on-year

Long term debt

$52.41M
RIGL annual long term debt is $52.41 million

Short term debt

$7.56M
RIGL annual short term debt is $7.56 million

Equity & Capital

Shareholders equity

$3.29M
RIGL annual stockholders equity is $3.29 million

Book value

$3.29M
RIGL annual book value is $3.29 million

Retained earnings

-$1.39B
RIGL annual retained earnings is -$1.39 billion

Working capital

$71.80M
RIGL annual working capital is $71.80 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$31.47M
RIGL annual cash flow from operations is $31.47 million

Cash from operations 1-year change

+647.99%
RIGL annual cash flow from operations is up +647.99% year-on-year

Cash from investing

$4.13M
RIGL annual cash flow from investing activities is $4.13 million

Cash from investing 1-year change

+196.11%
RIGL annual cash flow from investing activities is up +196.11% year-on-year

Cash from financing

-$11.64M
RIGL annual cash flow from financing activities is -$11.64 million

Cash from financing 1-year change

-163.38%
RIGL annual cash flow from financing activities is down -163.38% year-on-year

CAPEX

CAPEX

$396.00K
RIGL annual capital expenditures is $396.00 thousand

CAPEX 1-year change

-97.36%
RIGL annual capital expenditures is down -97.36% year-on-year

Free Cash Flow

Free cash flow

$31.07M
RIGL annual free cash flow is $31.07 million

Free cash flow 1-year change

+249.81%
RIGL annual free cash flow is up +249.81% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

89.60%
RIGL annual gross profit margin is 89.60%

Operating margin

13.49%
RIGL annual operating profit margin is 13.49%

Net margin

9.75%
RIGL annual net profit margin is 9.75%

ROA & ROE

ROA

12.44%
RIGL annual return on assets is 12.44%

ROE

531.78%
RIGL annual return on equity is 531.78%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

17.74
RIGL price to earnings ratio is 17.74

PE ratio Sector rank

33%
RIGL price to earnings ratio is higher than 33% of companies in Healthcare sector

PB Ratio

PB ratio

90.62
RIGL price to book ratio is 90.62

PB ratio Sector rank

99.26%
RIGL price to book ratio is higher than 99.26% of companies in Healthcare sector

PS Ratio

PS ratio

1.66
RIGL price to sales ratio is 1.66

PS ratio Sector rank

39.1%
RIGL price to sales ratio is higher than 39.1% of companies in Healthcare sector

Enterprise value

Enterprise value

$301.17M
RIGL enterprise value is $301.17 million

Enterprise value Sector rank

63.48%
RIGL enterprise value is higher than 63.48% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

10.56
RIGL EV/EBITDA is 10.56

EV/EBITDA Sector rank

83.16%
RIGL EV/EBITDA is higher than 83.16% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.13
RIGL annual current ratio is 2.13

Quick ratio

2.04
RIGL annual quick ratio is 2.04

Leverage

Debt to equity

18.15
RIGL annual debt to equity ratio is 18.15

Interest coverage ratio

3.32
RIGL annual interest coverage ratio is 3.32

Risk & Stability

Piotroski F-Score

8
RIGL piotroski f-score is 8

Altman Z-Score

-8.61
RIGL altman z-score is -8.61

Analyst ratings

Recent major analysts updates

Mar 6, 25 Citigroup
Buy
Mar 5, 25 HC Wainwright & Co.
Buy
Mar 5, 25 B. Riley Securities
Neutral
Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Jan 14, 25 HC Wainwright & Co.
Buy
Dec 10, 24 HC Wainwright & Co.
Buy
Dec 10, 24 Cantor Fitzgerald
Neutral
Dec 10, 24 B. Riley Securities
Neutral
Dec 6, 24 B. Riley Securities
Neutral

Institutional Ownership

Similar stocks

MREO logo
Mereo BioPharma (MREO)
TKNO logo
Alpha Teknova (TKNO)
IVA logo
Inventiva SA (IVA)
PHAT logo
Phathom Pharmaceuticals (PHAT)
TRDA logo
Entrada Therapeutics (TRDA)
ALLO logo
Allogene Therapeutics (ALLO)
DH logo
Definitive Healthcare (DH)
BNTC logo
Benitec Biopharma (BNTC)
NNOX logo
Nano-X Imaging (NNOX)
  • What is the ticker symbol for Rigel Pharmaceuticals?
  • Does Rigel Pharmaceuticals pay dividends?
  • What sector is Rigel Pharmaceuticals in?
  • What industry is Rigel Pharmaceuticals in?
  • What country is Rigel Pharmaceuticals based in?
  • When did Rigel Pharmaceuticals go public?
  • Is Rigel Pharmaceuticals in the S&P 500?
  • Is Rigel Pharmaceuticals in the NASDAQ 100?
  • Is Rigel Pharmaceuticals in the Dow Jones?
  • When was Rigel Pharmaceuticals's last earnings report?
  • When does Rigel Pharmaceuticals report earnings?
  • Should I buy Rigel Pharmaceuticals stock now?

What is the ticker symbol for Rigel Pharmaceuticals?

The ticker symbol for Rigel Pharmaceuticals is NASDAQ:RIGL

Does Rigel Pharmaceuticals pay dividends?

No, Rigel Pharmaceuticals does not pay dividends

What sector is Rigel Pharmaceuticals in?

Rigel Pharmaceuticals is in the Healthcare sector

What industry is Rigel Pharmaceuticals in?

Rigel Pharmaceuticals is in the Biotechnology industry

What country is Rigel Pharmaceuticals based in?

Rigel Pharmaceuticals is headquartered in United States

When did Rigel Pharmaceuticals go public?

Rigel Pharmaceuticals's initial public offering (IPO) was on November 29, 2000

Is Rigel Pharmaceuticals in the S&P 500?

No, Rigel Pharmaceuticals is not included in the S&P 500 index

Is Rigel Pharmaceuticals in the NASDAQ 100?

No, Rigel Pharmaceuticals is not included in the NASDAQ 100 index

Is Rigel Pharmaceuticals in the Dow Jones?

No, Rigel Pharmaceuticals is not included in the Dow Jones index

When was Rigel Pharmaceuticals's last earnings report?

Rigel Pharmaceuticals's most recent earnings report was on Mar 4, 2025

When does Rigel Pharmaceuticals report earnings?

The next expected earnings date for Rigel Pharmaceuticals is May 7, 2025

Should I buy Rigel Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page